Showing 3021-3030 of 10618 results for "".
What PAs Need to Know About Malpractice Coverage
https://reachmd.com/programs/partners-in-practice/what-pas-need-to-know-about-malpractice-coverage/6040/All PAs hope to never be sued. But if it happens, will malpractice coverage pay for legal costs and court awards? Is employer-provided malpractice coverage enough, and what are the differences between the types of policies? PA Jeff Nicholson, president of the American Academy of Physician AssistantsPreparing for Medicare Payment Cuts
https://reachmd.com/programs/heart-matters/preparing-for-medicare-payment-cuts/5183/What payment cuts does the 2010 Medicare Physician Fee Schedule include for cardiology? How will these lower reimbursements affect cardiology practices and impact patients' access to care? Chris Kaiser, editor of Cardiovascular Business, joins host Dr. Jack Lewin to discuss ways cardiology practicesAddressing Vascular Plaque Ruptures
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/addressing-vascular-plaque-ruptures/3131/A ruptured vascular plaque with subsequent thrombus often triggers the heart attack that occurs without warning. How do we identify and treat at-risk cardiac patients? Host Dr. Lee Freedman discusses an array of tools to evaluate plaque burden and promote plaque stabilization with Dr. Emile Mohler IGenetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease
https://reachmd.com/programs/lipid-luminations/genetic-testing-to-improve-risk-assessment-and-guide-therapies-in-patients-facing-heart-disease/6481/Dr. Christie Ballantyne discusses with host Dr. Alan Brown the use of genetic testing in various phases of disease onset in patients facing heart disease. They talk about how clinicians can utilize the current technologies, what the costs are and the benefits. How does learning more about the genetiUnderstanding the Growing Burden of Early-Onset CRC
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/growing-burden-early-onset-crc/49178/Colorectal cancer is rising rapidly among adults under 50, often presenting at more advanced stages. Dr. Christopher Cann joins host Ryan Quigley to review key considerations for this population, including key diagnostic and therapeutic strategies, survivorship concerns, and multidisciplinary caNegotiation and Disruptive Innovation in Academic Allergy Practice
https://reachmd.com/programs/clinicians-roundtable/negotiation-disruptive-innovation-academic-allergy/54735/Financial and space limitations are two of the most pressing issues facing allergists and immunologists in academic practice. Fortunately, negotiation principles, like BATNA and ZOPA, and disruptive innovation tactics can help address these common issues. To learn more, we recently spoke with Dr. MaInside the COVID-19 Response: Scientific Rigor Amid Uncertainty
https://reachmd.com/programs/clinicians-roundtable/covid-19-response-scientific-rigor/48835/During the COVID-19 pandemic, healthcare leaders navigated a turbulent scientific landscape while upholding a consistent, evidence-based process for decision-making. Dr. Jason Goldman, the President of the American College of Physicians as well as their liaison to the CDC Advisory Committee on ImmunEncouraging Conversation
https://reachmd.com/topics/skin-cancer-photoprotection/encouraging-conversation-40-gep-testing-for-adjuvant-radiation-therapy-candidates/37104/Two studies validate the 40-GEP test for identifying patients most likely to benefit from adjuvant radiation therapyAddressing Barriers to Colorectal Cancer Screening in Rural Populations
https://reachmd.com/programs/clinicians-roundtable/addressing-barriers-to-colorectal-cancer-screening-in-rural-populations/33056/Rural populations face unique challenges in accessing colorectal cancer screening, leaving many patients in these communities unscreened. However, mailed fecal immunochemical testing (FIT) may help address these barriers and improve adherence. Joining Dr. Peter Buch to discuss the benefits and limitGenetics and Schizophrenia: Key Ethical Considerations
https://reachmd.com/programs/neurofrontiers/genetics-and-schizophrenia-key-ethical-considerations/32749/Learn more about ethical challenges in genetic tools used for schizophrenia management.